Targeting glycan sulfation in a CD11c+ myeloid population inhibits early KRAS-mutant lung neoplasia1☆☆☆

MLA

Kim, So Young, et al. “Targeting Glycan Sulfation in a CD11c+ Myeloid Population Inhibits Early KRAS-Mutant Lung Neoplasia1☆☆☆.” Neoplasia (New York, N.Y.), vol. 23, no. 11, Oct. 2021, pp. 1137–43. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........6c1a8c4e83557920ae120f81f6685b95&authtype=sso&custid=ns315887.

APA

Kim, S. Y., Johns, S. C., Gupta, P., Varki, N., & Fuster, M. M. (2021). Targeting glycan sulfation in a CD11c+ myeloid population inhibits early KRAS-mutant lung neoplasia1☆☆☆. Neoplasia (New York, N.Y.), 23(11), 1137–1143.

Chicago

Kim, So Young, Scott C. Johns, Purva Gupta, Nissi Varki, and Mark M Fuster. 2021. “Targeting Glycan Sulfation in a CD11c+ Myeloid Population Inhibits Early KRAS-Mutant Lung Neoplasia1☆☆☆.” Neoplasia (New York, N.Y.) 23 (11): 1137–43. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........6c1a8c4e83557920ae120f81f6685b95&authtype=sso&custid=ns315887.